These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29719590)

  • 1. 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
    Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
    Oncotarget; 2018 Apr; 9(26):18053-18068. PubMed ID: 29719590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2'-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76.
    Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
    Mol Carcinog; 2018 Dec; 57(12):1751-1762. PubMed ID: 30136444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Hydroxyflavanone induced changes in the proteomic profile of breast cancer cells.
    Nagaprashantha LD; Singhal J; Chikara S; Gugiu G; Horne D; Awasthi S; Salgia R; Singhal SS
    J Proteomics; 2019 Feb; 192():233-245. PubMed ID: 30248461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-Hydroxyflavanone: A novel strategy for targeting breast cancer.
    Singhal J; Nagaprashantha L; Chikara S; Awasthi S; Horne D; Singhal SS
    Oncotarget; 2017 Sep; 8(43):75025-75037. PubMed ID: 29088842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 2'-Hydroxyflavanone for Cutaneous Melanoma.
    Bose C; Singh SP; Igid H; Green WC; Singhal SS; Lee J; Palade PT; Rajan A; Ball S; Tonk V; Hindle A; Tarbox M; Awasthi S
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31615091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity of 2'-hydroxyflavanone towards lung cancer.
    Awasthi S; Singhal SS; Singhal J; Nagaprashantha L; Li H; Yuan YC; Liu Z; Berz D; Igid H; Green WC; Tijani L; Tonk V; Rajan A; Awasthi Y; Singh SP
    Oncotarget; 2018 Nov; 9(90):36202-36219. PubMed ID: 30546837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic efficacy of RLIP inhibition and 2'-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice.
    Singhal SS; Horne D; Singhal J; Vonderfecht S; Salgia R; Awasthi S
    Mol Carcinog; 2019 Aug; 58(8):1438-1449. PubMed ID: 31006917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RLIP inhibition suppresses breast-to-lung metastasis.
    Singhal J; Chikara S; Horne D; Salgia R; Awasthi S; Singhal SS
    Cancer Lett; 2019 Apr; 447():24-32. PubMed ID: 30684594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis of breast tumor cells to brain is suppressed by targeting RLIP alone and in combination with 2'-Hydroxyflavanone.
    Singhal J; Singhal P; Horne D; Salgia R; Awasthi S; Singhal SS
    Cancer Lett; 2018 Dec; 438():144-153. PubMed ID: 30223070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
    Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
    Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells.
    Chang CJ; Chiu JH; Tseng LM; Chang CH; Chien TM; Wu CW; Lui WY
    Eur J Clin Invest; 2006 Aug; 36(8):588-96. PubMed ID: 16893382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
    Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
    Oncotarget; 2022; 13():331. PubMed ID: 35261722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.
    Nagaprashantha LD; Vatsyayan R; Singhal J; Lelsani P; Prokai L; Awasthi S; Singhal SS
    Carcinogenesis; 2011 Apr; 32(4):568-75. PubMed ID: 21304051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells.
    Peng J; Jordan VC
    Int J Oncol; 2010 Feb; 36(2):451-8. PubMed ID: 20043081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines.
    Rangel N; Villegas VE; Rondón-Lagos M
    Breast Cancer (Dove Med Press); 2017; 9():537-550. PubMed ID: 29033607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
    Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
    Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibitory potencies and mechanisms of the type I ribosome inactivating protein marmorin on estrogen receptor (ER)-positive and ER-negative breast cancer cells.
    Pan WL; Wong JH; Fang EF; Chan YS; Ye XJ; Ng TB
    Biochim Biophys Acta; 2013 May; 1833(5):987-96. PubMed ID: 23274857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
    Leake K; Singhal J; Nagaprashantha LD; Awasthi S; Singhal SS
    PLoS One; 2012; 7(4):e34582. PubMed ID: 22509328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rlip Depletion Suppresses Growth of Breast Cancer.
    Bose C; Yadav S; Singhal SS; Singhal J; Hindle A; Lee J; Cheedella NKS; Rehman S; Rahman RL; Jones C; Darden M; Palade PT; Berz D; Singh SP; Awasthi S
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32498332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
    Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.